2023/06/12
プレスルーム
『海外』Weekly ニュース (2023/06/12 ～ )
🚩 あれ？リンクがない？！
※ ログインのご案内
本記事２ページ目には、各情報へのURL(リンク) ならびに 編集部コメント[ Editor's 👀 Eye ] が追記されています。
是非とも(無料)会員登録の上、ログインしてご利用ください。
(登録 2023/06/21)
📢 Tivic Health® Systems, Inc. (https://)
Tivic ClearUP Expands Target Market Offering to Include Individuals Who Are Sleep Deprived, Medication Restricted, and Athletes (https://)
📢 Novarad Corporation (https://)
Revolutionizing Cranial Neurosurgery: Novarad's VisAR Augmented Reality System Shatters Surgical Boundaries (https://)
(登録 2023/06/21)
📢 AND Health, LLC (https://)
Quantum Health Selects AndHealth to Provide New Migraine Reversal Program for Employees (https://)
📢 XRHealth USA Inc. (https://)
XRHealth Awarded Patent for Closed Loop Biofeedback for Therapy in Virtual Reality and Augmented Reality (https://)
(登録 2023/06/21)
📢 PEARL, INC. (https://)
Pearl Receives Industry-First EU-MDR Certification for Second Opinion® AI Platform (https://)
Pearl’s flagship solution becomes the first and only AI-based dental pathology detection software to be certified as a Class IIa medical device under EU-MDR
📢 Brookdale Senior Living (https://)
Cognitive Wellness: Spotlighting Brain Health during Alzheimer's and Brain Awareness Month (https://)
📢 SimpleTherapy Inc. (https://)
New Study Reveals SimpleTherapy's Exercise Therapy Program Offers Pain Reduction, Improved Quality of Life, and Work Productivity, with Enhanced Engagement and Accessibility (https://)
📢 Medivis (https://)
Medivis Raises $20M Series A to Advance Surgery with Augmented Reality (https://)
📢 Uber Health (https://)
Uber Health Expands First-of-its-kind Platform, Launching Grocery and Over-the-Counter Item Delivery to Patient Homes Nationwide (https://)
(登録 2023/06/21)
📢 Qbtech AB (https://)
Qbtech: Telehealth is Not Jeopardizing ADHD Care - It’s Expanding It (https://)
Global Leader in Objective ADHD Testing Shares Concerns for Misdirected Focus on Improving ADHD Care
📢 Zhongchao Inc. (https://)
Zhongchao Inc. Launch Digital Online Education Platform for Common Diseases Clinical Diagnosis and Treatment (https://)
📢 Huma Therapeutics Limited (https://)
Huma receives multi-condition US FDA 510(k) Class II regulatory clearance for its configurable SaMD disease management platform (https://)
以上
連載記事
